Spiolto Respimat is a prescription medication used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is a combination inhaler that contains two active ingredients: tiotropium bromide and olodaterol. Tiotropium bromide is a long-acting muscarinic antagonist (LAMA), also known as an anticholinergic, which works by relaxing the muscles around the airways in the lungs, making it easier to breathe. Olodaterol is a long-acting beta-adrenoceptor agonist (LABA) that further helps to open the airways and prevent bronchospasm. The Spiolto Respimat inhaler is specifically designed to deliver the medication as a fine mist, making it easier for patients to inhale the medication deep into the lungs. It is used once daily and is intended to improve lung function, reduce symptoms, and prevent exacerbations in adults with COPD.